Cartesian Therapeutics
RNAC
RNAC
61 hedge funds and large institutions have $136M invested in Cartesian Therapeutics in 2020 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
+23
Holders Change %
+60.53%
% of All Funds
1.35%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
30
Increased
17
Reduced
6
Closed
6
Calls
$70K
Puts
$1K
Net Calls
+$69K
Net Calls Change
+$69K
Top Buyers
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
+$18.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$4.09M |
| 3 |
Millennium Management
New York
|
+$2.85M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$2.68M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$2.1M |
Top Sellers
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$2.88M |
| 2 |
Man Group
London,
United Kingdom
|
-$1.98M |
| 3 |
SRF
Silver Rock Financial
Los Angeles,
California
|
-$1.09M |
| 4 |
O
OrbiMed
New York
|
-$687K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$395K |
